Ignite Creation Date:
2024-05-06 @ 9:26 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02988817
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2016-12-01
Brief Title:
Enapotamab Vedotin HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Sponsor:
Organization:
Genmab